These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38316196)

  • 1. P300 in schizophrenia: Then and now.
    Hamilton HK; Mathalon DH; Ford JM
    Biol Psychol; 2024 Mar; 187():108757. PubMed ID: 38316196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auditory and Visual Oddball Stimulus Processing Deficits in Schizophrenia and the Psychosis Risk Syndrome: Forecasting Psychosis Risk With P300.
    Hamilton HK; Woods SW; Roach BJ; Llerena K; McGlashan TH; Srihari VH; Ford JM; Mathalon DH
    Schizophr Bull; 2019 Sep; 45(5):1068-1080. PubMed ID: 30753731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P300 amplitude attenuation in high risk and early onset psychosis youth.
    Graber K; Bosquet Enlow M; Duffy FH; D'Angelo E; Sideridis G; Hyde DE; Morelli N; Tembulkar S; Gonzalez-Heydrich J
    Schizophr Res; 2019 Aug; 210():228-238. PubMed ID: 30685392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory P300 event related potentials in acute and transient psychosis-Comparison with schizophrenia.
    Sahoo S; Malhotra S; Basu D; Modi M
    Asian J Psychiatr; 2016 Oct; 23():8-16. PubMed ID: 27969085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome.
    Hamilton HK; Roach BJ; Bachman PM; Belger A; Carrion RE; Duncan E; Johannesen JK; Light GA; Niznikiewicz MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cannon TD; Mathalon DH
    JAMA Psychiatry; 2019 Nov; 76(11):1187-1197. PubMed ID: 31389974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of auditory target P300 subcomponents in psychosis: Differential diagnosis, symptom profiles, and course.
    Perlman G; Foti D; Jackson F; Kotov R; Constantino E; Hajcak G
    Schizophr Res; 2015 Jul; 165(2-3):145-51. PubMed ID: 25934167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic specificity of neurophysiological endophenotypes in schizophrenia and bipolar disorder.
    Johannesen JK; O'Donnell BF; Shekhar A; McGrew JH; Hetrick WP
    Schizophr Bull; 2013 Nov; 39(6):1219-29. PubMed ID: 22927673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroencephalography for the Study of the Auditory P300 Evoked Potential and Derived Measurements.
    Beño-Ruiz-de-la-Sierra RM; Fernández-Linsenbarth I; Roig-Herrero A; Díez-Revuelta Á
    Methods Mol Biol; 2023; 2687():93-106. PubMed ID: 37464165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evoked potentials N200/P300 disorders and clinical phenotype in Cuban families with paranoid schizophrenia: a family-based association study].
    Guerra López S; Martín Reyes M; Pedroso Rodríguez Mde L; Reyes Berazain A; Mendoza Quiñones R; Bravo Collazo TM; Días de Villarvilla T; Machado Cano MJ; Bobés León MA
    Medwave; 2015 Apr; 15(3):e6112. PubMed ID: 25919584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between hippocampal volume and P300 event related potential in psychosis: support for the Kraepelinian divide.
    Dutt A; Ganguly T; Shaikh M; Walshe M; Schulze K; Marshall N; Constante M; McDonald C; Murray RM; Allin MP; Bramon E
    Neuroimage; 2012 Jan; 59(2):997-1003. PubMed ID: 21924362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroencephalography and Event-Related Potential Biomarkers in Individuals at Clinical High Risk for Psychosis.
    Hamilton HK; Boos AK; Mathalon DH
    Biol Psychiatry; 2020 Aug; 88(4):294-303. PubMed ID: 32507388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can P300 distinguish among schizophrenia, schizoaffective and bipolar I disorders? An ERP study of response inhibition.
    Chun J; Karam ZN; Marzinzik F; Kamali M; O'Donnell L; Tso IF; Manschreck TC; McInnis M; Deldin PJ
    Schizophr Res; 2013 Dec; 151(1-3):175-84. PubMed ID: 24210871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of DISC1 on the P300 waveform in psychosis.
    Shaikh M; Hall MH; Schulze K; Dutt A; Li K; Williams I; Walshe M; Constante M; Broome M; Picchioni M; Toulopoulou T; Collier D; Stahl D; Rijsdijk F; Powell J; Murray RM; Arranz M; Bramon E
    Schizophr Bull; 2013 Jan; 39(1):161-7. PubMed ID: 21878470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of P300 amplitude in the diagnosis of untreated first-episode schizophrenia and psychosis risk syndrome in children and adolescents.
    Zhang Y; Yang T; He Y; Meng F; Zhang K; Jin X; Cui X; Luo X
    BMC Psychiatry; 2023 Oct; 23(1):743. PubMed ID: 37828471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismatch Negativity But Not P300 Is Associated With Functional Disability in Schizophrenia.
    Hamilton HK; Perez VB; Ford JM; Roach BJ; Jaeger J; Mathalon DH
    Schizophr Bull; 2018 Apr; 44(3):492-504. PubMed ID: 29036701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactive ERP recording increases the amplitude of the endogenous P300 peak in schizophrenia.
    Price GW
    Schizophr Res; 2000 Feb; 41(3):463-72. PubMed ID: 10728723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decomposing P300 into correlates of genetic risk and current symptoms in schizophrenia: An inter-trial variability analysis.
    Kim M; Lee TH; Kim JH; Hong H; Lee TY; Lee Y; Salisbury DF; Kwon JS
    Schizophr Res; 2018 Feb; 192():232-239. PubMed ID: 28400070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrophysiology and schizophrenic vulnerability: the P300 component as endophenotype candidate?].
    Cermolacce M; Micoulaud JA; Naudin J; Vion-Dury J
    Encephale; 2011 Oct; 37(5):353-60. PubMed ID: 22032278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double dissociation between P300 components and task switch error type in healthy but not psychosis participants.
    Huang LY; Parker DA; Ethridge LE; Hamm JP; Keedy SS; Tamminga CA; Pearlson GD; Keshavan MS; Hill SK; Sweeney JA; McDowell JE; Clementz BA
    Schizophr Res; 2023 Nov; 261():161-169. PubMed ID: 37776647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2.
    Turetsky BI; Dress EM; Braff DL; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Radant AD; Seidman LJ; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Swerdlow NR; Tsuang DW; Tsuang MT; Light G
    Schizophr Res; 2015 Apr; 163(1-3):53-62. PubMed ID: 25306203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.